Synteract

With800 staff members across 21 countries, Synteract is an international clinical research organization with a successful three-decade track record supporting biotechnology, medical device, and pharmaceutical companies in all phases of clinical development. Synteract has conducted PhaseI-IV studies on six continents and in more than 60 countries, offering broadtherapeutic expertise, with notable depth in oncology, immunotherapy, CNS, and infectious disease, among other indications. With its“Shared Work – Shared Vision” philosophy, Synteract provides customized services collaboratively and cost effectively, ensuringon-time delivery of quality data to help bring tomorrow's-treatments to patients.